Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

DermTech Q4 2023 GAAP EPS $(0.560) Beats $(0.570) Estimate, Sales $3.924M Miss $4.044M Estimate

Author: Benzinga Newsdesk | February 29, 2024 05:02pm
DermTech (NASDAQ:DMTK) reported quarterly losses of $(0.560) per share which beat the analyst consensus estimate of $(0.570) by 1.75 percent. The company reported quarterly sales of $3.924 million which missed the analyst consensus estimate of $4.044 million by 2.98 percent. This is a 31.06 percent increase over sales of $2.994 million the same period last year.

Posted In: DMTK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist